http://mobihealthnews.com/46267/leo-pharma-leads-3-4m-investment-in-melanoma-app-skinvision/
From their website;
Amsterdam-based dermatology app company SkinVision has raised $3.4 million from pharmaceutical company Leo Pharma with contributions from SkinVision’s existing investor and majority stakeholder Dutch investment firm Personal Health Solutions Capital. The complany plans to use the funding to move its app’s capabilities beyond melanoma recognition and into other skin conditions, according to a report in TechCrunch.
